Ghent University Academic Bibliography

International eDelphi study to reach consensus on the methotrexate dosing regimen in patients with psoriasis

Astrid M. van Huizen, Stef P. Menting, Rolland Gyulai, Lars Iversen, Gayle E. van der Kraaij, Maritza A. Middelkamp-Hup, Richard B. Warren, Phyllis I. Spuls, Adrián A. Schejtman, Alexander Egeberg, et al.

(2022) JAMA DERMATOLOGY. 158(5). p.561-572

Add to list

Journal Article
A1
open access

Biologic therapies for severe asthma

Guy Brusselle (UGent) and Gerard H. Koppelman

(2022) NEW ENGLAND JOURNAL OF MEDICINE. 386(2). p.157-171

Add to list

Journal Article
A1
open access

Long‐term efficacy and safety of brodalumab in moderate‐to‐severe plaque psoriasis : a post hoc pooled analysis of AMAGINE‐2 and ‐3

K. Reich, L. Iversen, L. Puig, Johannes Lambert, U. Mrowietz, K. Kaplan Saday and R.B. Warren

(2022) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 36(8). p.1275-1283

Add to list

Journal Article
A1
open access

Real-life effectiveness of mepolizumab in severe asthma : a systematic literature review

Elliot Israel, Giorgio Walter Canonica, Guy Brusselle (UGent) , Shibing Yang, Peter H. Howarth, Amber L. Martin, Maria Koufopoulou, Steven G. Smith and Rafael Alfonso-Cristancho

(2022) JOURNAL OF ASTHMA.

Add to list

Journal Article
A1
open access

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 205(1). p.17-35

Add to list

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) ARCHIVOS DE BRONCONEUMOLOGIA. 58(1). p.35-51

Add to list

Journal Article
A1
open access

Global initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) EUROPEAN RESPIRATORY JOURNAL. 59(1).

Add to list

Journal Article
A1
open access

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(1). p.S1-S18

Add to list

Journal Article
A1
open access

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle (UGent) , Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.

(2022) RESPIROLOGY. 27(1). p.14-35

Add to list

Anti–interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry

Sophie Graff, Guy Brusselle (UGent) , Shane Hanon, Carine Sohy, Lieven Dupont, Rudy Peche, Alain Michils, Charles Pilette, Guy Joos (UGent) , Lies Lahousse (UGent) , et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(2). p.467-477

Academic Bibliography

International eDelphi study to reach consensus on the methotrexate dosing regimen in patients with psoriasis

Biologic therapies for severe asthma

Long‐term efficacy and safety of brodalumab in moderate‐to‐severe plaque psoriasis : a post hoc pooled analysis of AMAGINE‐2 and ‐3

Real-life effectiveness of mepolizumab in severe asthma : a systematic literature review

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes

Anti–interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry

Contents

Support

Contact